Operations shut down with parent company's bankruptcy
Headquarters
South San Francisco, California
,
United States
Parent
diaDexus, Inc. (from 2010)
VaxGen was a biopharmaceutical company based in the San Francisco Bay Area.
Founded in 1995 and based in South San Francisco, California, the company was engaged in the development of vaccines that immunize against infectious disease, notably AIDS. On July 28, 2010, VaxGen Inc. was acquired by diaDexus, Inc. in a reverse merger transaction.;[1] diaDexus filed for bankruptcy in 2016.[2] VaxGen, Inc. does not have significant operations.
^"VaxGen to Acquire diaDexus in a Stock-for-Stock Merger Under Revised Terms". Diadexus.
^Area's diaDexus Files Chapter 7 Bankruptcy, Plans to Liquidate Assets, CFO to Step Down Immediately, Mark Terry, BioSpace.com published 14 June 2016
various biodefense vaccines. Historically was http://www.VaxGen.com. This URL is no longer for the Vaxgen, Inc. in this article. Companies portal v t e...
Co-Founder, VaxGen Inc. The VaxGen Experiment, London Sunday Times, 3 October 1999 Vaccine has no impact; AIDSVAX's failure a blow to treatment VaxGen Announces...
originally at Genentech in San Francisco, California, and later tested by the VaxGen company, a Genentech offshoot. The development and trials of the vaccine...
would be a success. She joined VaxGen in 2004, where she was appointed chief scientific officer. In 2006 Jansen left VaxGen to join Wyeth Pharmaceuticals...
BioThrax is the only anthrax vaccine licensed by the FDA. Another company, VaxGen had received an $877.5 million contract to produce an alternative anthrax...
genetically engineered anthrax vaccine. San Francisco-area biotechnology company VaxGen licensed the vaccine and won a federal contract valued at $877.5 million...
preventive HIV vaccine candidates have entered Phase III. In February 2003, VaxGen announced that their AIDSVAX B/E vaccine was a failure in North America...
2008) Vaxgen anthrax vaccine contract information. Archived 31 December 2006 at the Wayback Machine Heavey S (20 December 2006). "U.S. cancels VaxGen anthrax...
Pharmaceuticals, Theravance, AnorMed, Idera Pharmaceuticals, Phase Forward and VaxGen. An amateur flutist, she has appeared as soloist with Arthur Fiedler and...
serving early stage health care and technology companies. Caudill serves on VaxGen board's Audit Committee and Compensation Committee and the Genentech Contract...
Lilly), Orchid Biosciences (acquired by LapCorp), diaDexus (acquired by Vaxgen), Monsanto (acquired by Bayer) and Advanced PCS (acquired by CVS-Caremark)...
Commission. March 22, 1999. "Company Briefs". The New York Times. May 29, 2003. "VaxGen, Medarex Rise Amid News on Anthrax". The Wall Street Journal. May 28, 2003...
"Gen. Petraeus says Ukraine, military readiness top priorities for NDAA, vax mandate outrage 'manufactured'". Fox News. Retrieved March 4, 2023. "Gen....
was a mini-supercomputer: a category of computers that was larger than a VAX 11/780 and smaller than a mainframe. This market segment disappeared as high-end...
from those of other FCV isolates". J Gen Virol. 88 (Pt 2): 506–17. doi:10.1099/vir.0.82488-0. PMID 17251569. "CaliciVax updated to cover virulent systemic...
Global Information